Jennifer Nessel, Assistant Editor

The decline in the cancer mortality rate attributed to immunotherapy methods, early detection, and treatment.

Independent pharmacists have noted a growing trend in which Amazon’s Pillpack is sending unsolicited phone calls to their patients as a way of requesting transfers of prescriptions.

After injecting the flu vaccine into a tumor cell, researchers found that the injection either slowed the growth or shrunk the tumor itself.

The Supreme Court released their decision to review Rutledge v. Pharmaceutical Care Management Association, which could affect pharmacy benefits across the country.

Through the Ready, Set, PrEP program, qualified patients from across the United States can access PrEP medication for the prevention of HIV, for free.

Micafungin injection is the first antifungal drug approved in the United States specifically for pediatric patients younger than 4 years of age with invasive candidiasis.

Secukinumab provided early and sustained resolution of enthesitis in patients with psoriatic arthritis based on post hoc analysis pooled data from the FUTURE trial.

Through the Automatic LifeStyle Advice platform, health service providers can integrate personal health trackers, allowing data to configure the optimal recommendation for diet, exercise, and daily health management.

Study seeks to determine how HIV avoids the zinc-finger antiviral protein and how it binds the RNA.

Dietary supplements containing zinc and folic acid marketed as a treatment for male infertility do not appear to improve pregnancy rates.

Manufacturers have selected AllianceRx Walgreens as their limited distribution drug partner for drugs that treat conditions such as myelofibrosis, cystic fibrosis, and non-metastatic castration-resistant prostate cancer.

The Prescription Drug User Fee Act date, the FDA action data for this supplemental application, is scheduled for the second quarter of 2020.

A study suggests that even brief art-making interventions can be beneficial for stressed caregivers of patients with cancer.

Researchers investigate whether on-demand pre-exposure prophylaxis was similarly effective among individuals with lower exposure to HIV risk.

According to the study authors, such “anti-austerity agents” represent a promising approach to cancer chemotherapy.

The study led to insight on the process of tuberculosis bacillus infection as well as a potential drug treatment.

Abemaciclib is a potent oral cyclin-dependent kinase 4/6 inhibitor that has previously demonstrated statistically significant improvement in PFS and ORR in combination with endocrine therapy.

Novadoz Pharmaceuticals, who markets the product, has commenced shipping of the drug, available in bottles of 30 tablets.

Stuck in the pharmacy during the New Year’s Eve festivities? This Pharmacy Times countdown has everything you need for celebrating the holiday with your pharmacy team.

The results of a new study published in the Annals of Internal Medicine demonstrate the need for increased awareness of mental health disorders among adults with cerebral palsy.

Researchers may have found a way to stop the driving force at a molecular level behind acute lymphoblastic leukemia.

Patients with epilepsy treated with perampanel during routine clinical care had favorable retention rates and sustained efficacy.

A study found that intravenous immune globulin dosing optimization through alternative dosing weights represents a significant source of waste reduction and cost reduction.

Many individuals with HIV who are receiving antiretroviral therapy have viral genetic material in the cells of their cerebrospinal fluid, making them more likely to experience memory and concentration problems, according to the results of a new study.

Oncolytic Viral Therapy (OVT) is currently not recognized by treatment guidelines for advanced pancreatic cancer; however, safety and efficacy data from previous studies conducted over the previous 10 years have shown that OVT may be a promising, innovative approach for patients with pancreatic cancer.

A study found that the total prescriptions for gabapentinoid medications grew from 1.2 million to 3.5 million between 2005-2015.

Abemacilib is an oral selective inhibitor of cyclin-dependent kinases 4 and 6 approved for hormone receptor, human epidermal growth factor receptor 2 metastatic breast cancer.

Enfortumab vedotin-ejfv is the first FDA-approved treatment in the United States for this patient population.

Inflammation from beta blockers is caused by a cellular process known as autophagy.

A study sought to determine how HIV avoids the antiviral protein, zinc-finger antiviral protein.